• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于片段的分子进化方法从头设计类药性分子。

De novo design of drug-like molecules by a fragment-based molecular evolutionary approach.

机构信息

Central Research Laboratories, Kaken Pharmaceutical Co. Ltd. , 14, Shinomiya Minamikawara-cho, Yamashina, Kyoto 607-8042, Japan.

出版信息

J Chem Inf Model. 2014 Jan 27;54(1):49-56. doi: 10.1021/ci400418c. Epub 2014 Jan 13.

DOI:10.1021/ci400418c
PMID:24372539
Abstract

This paper describes a similarity-driven simple evolutionary approach to producing candidate molecules of new drugs. The aim of the method is to explore the candidates that are structurally similar to the reference molecule and yet somewhat different in not only peripheral chains but also their scaffolds. The method employs a known active molecule of our interest as a reference molecule which is used to navigate a huge chemical space. The reference molecule is also used to obtain seed fragments. An initial set of individual structures is prepared with the seed fragments and additional fragments using several connection rules. The fragment library is preferably prepared from a collection of known molecules related to the target of the reference molecule. Every fragment of the library can be used for fragment-based mutation. All the fragments are categorized into three classes; rings, linkers, and side chains. New individuals are produced by the crossover and the fragment-based mutation with the fragment library. Computer experiments with our own fragment library prepared from GPCR SARfari verified the feasibility of our approach to drug discovery.

摘要

本文描述了一种基于相似性的简单进化方法,用于生成新药物的候选分子。该方法的目的是探索与参考分子在结构上相似但不仅在侧链而且在其支架上有所不同的候选分子。该方法使用我们感兴趣的已知活性分子作为参考分子,用于在巨大的化学空间中导航。参考分子也用于获得种子片段。使用几个连接规则,用种子片段和其他片段准备初始的一组个体结构。片段库最好从与参考分子的靶标相关的已知分子的集合中制备。库中的每个片段都可以用于基于片段的突变。所有片段都分为三类:环、接头和侧链。使用片段库通过交叉和基于片段的突变生成新个体。使用我们自己从 GPCR SARfari 制备的片段库进行计算机实验验证了我们的药物发现方法的可行性。

相似文献

1
De novo design of drug-like molecules by a fragment-based molecular evolutionary approach.基于片段的分子进化方法从头设计类药性分子。
J Chem Inf Model. 2014 Jan 27;54(1):49-56. doi: 10.1021/ci400418c. Epub 2014 Jan 13.
2
[In Silico Drug Design Using an Evolutionary Algorithm and Compound Database].[使用进化算法和化合物数据库的计算机辅助药物设计]
Yakugaku Zasshi. 2016;136(1):107-12. doi: 10.1248/yakushi.15-00230-3.
3
In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.基于片段的计算机药物发现:使用 S4MPLE 建立和验证片段至先导物的计算方案。
J Chem Inf Model. 2013 Apr 22;53(4):836-51. doi: 10.1021/ci4000163. Epub 2013 Apr 11.
4
Chemical fragment spaces for de novo design.用于从头设计的化学片段空间。
J Chem Inf Model. 2007 Mar-Apr;47(2):318-24. doi: 10.1021/ci6003652. Epub 2007 Feb 15.
5
How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.多样性评估方法有哪些差异?分子描述符空间的比较分析和基准测试。
J Chem Inf Model. 2014 Jan 27;54(1):230-42. doi: 10.1021/ci400469u. Epub 2013 Dec 13.
6
Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design.通量(2):基于配体的从头设计中分子突变和交叉算子的比较。
J Chem Inf Model. 2007 Mar-Apr;47(2):656-67. doi: 10.1021/ci6005307. Epub 2007 Feb 23.
7
Tagged fragment method for evolutionary structure-based de novo lead generation and optimization.基于进化结构的从头药物设计与优化的标记片段方法
J Med Chem. 2007 Nov 1;50(22):5392-402. doi: 10.1021/jm070750k. Epub 2007 Oct 6.
8
SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.SABRE:基于配体/结构的虚拟筛选方法,使用共识分子形状模式识别。
J Chem Inf Model. 2014 Jan 27;54(1):338-46. doi: 10.1021/ci4005496. Epub 2013 Dec 23.
9
Maximizing discovery efficiency with a computationally driven fragment approach.采用计算驱动的片段方法最大化发现效率。
Curr Opin Drug Discov Devel. 2005 May;8(3):355-64.
10
Prediction of new bioactive molecules using a Bayesian belief network.基于贝叶斯信念网络的新型生物活性分子预测。
J Chem Inf Model. 2014 Jan 27;54(1):30-6. doi: 10.1021/ci4004909. Epub 2014 Jan 15.

引用本文的文献

1
Effective generation of heavy-atom-free triplet photosensitizers containing multiple intersystem crossing mechanisms based on deep learning.基于深度学习有效生成包含多种系间窜越机制的无重原子三重态光敏剂。
Chem Sci. 2025 Jul 8. doi: 10.1039/d5sc03192c.
2
Adaptive Space Search-based Molecular Evolution Optimization Algorithm.基于自适应空间搜索的分子进化优化算法
Bioinformatics. 2024 Jul 23;40(7). doi: 10.1093/bioinformatics/btae446.
3
Integrated Molecular Modeling and Machine Learning for Drug Design.基于分子模拟的药物设计与机器学习的整合。
J Chem Theory Comput. 2023 Nov 14;19(21):7478-7495. doi: 10.1021/acs.jctc.3c00814. Epub 2023 Oct 26.
4
Development and application of fragment-based de novo inhibitor design approaches against Plasmodium falciparum GST.针对恶性疟原虫 GST 的从头抑制剂设计方法的开发与应用
J Mol Model. 2023 Aug 16;29(9):281. doi: 10.1007/s00894-023-05650-0.
5
Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and -Secretase 1: Next Generation for Alzheimer's Disease Treatment.针对人类乙酰胆碱酯酶、丁酰胆碱酯酶和β-分泌酶1的分子多靶点方法:阿尔茨海默病治疗的新一代方案
Pharmaceuticals (Basel). 2023 Jun 15;16(6):880. doi: 10.3390/ph16060880.
6
Structure-based drug design-guided identification of estrogen receptor binders.基于结构的药物设计指导下的雌激素受体配体的鉴定。
Mol Divers. 2024 Jun;28(3):1291-1303. doi: 10.1007/s11030-023-10657-z. Epub 2023 Jun 8.
7
Introducing ligand GA, a genetic algorithm molecular tool for automated protein inhibitor design.介绍配体 GA,一种用于自动蛋白质抑制剂设计的遗传算法分子工具。
Sci Rep. 2022 Dec 3;12(1):20877. doi: 10.1038/s41598-022-22281-2.
8
Artificial Intelligence in Drug Design: Are We Still There?药物设计中的人工智能:我们还在那里吗?
Curr Top Med Chem. 2022;22(30):2483-2492. doi: 10.2174/1568026623666221017143244.
9
A molecular evolution algorithm for ligand design in DOCK.DOCK 中配体设计的分子进化算法。
J Comput Chem. 2022 Nov 5;43(29):1942-1963. doi: 10.1002/jcc.26993. Epub 2022 Sep 8.
10
Protein-Ligand Docking in the Machine-Learning Era.蛋白质-配体对接在机器学习时代。
Molecules. 2022 Jul 18;27(14):4568. doi: 10.3390/molecules27144568.